A lab outside Rome took “seed stock” produced at Oxford. Now U.S. and European officials are showing signs of support. That vaccine, like all the others designed to combat the pandemic, remains unproved. But it is further along in the trial process than the others, and it has turned into the West’s best — and perhaps only — chance to have a viable vaccine before the end of the year.
Publisher: Washington Post | Author: Chico Harlan